Correlation Between Ascletis Pharma and Ignyte Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ascletis Pharma and Ignyte Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascletis Pharma and Ignyte Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascletis Pharma and Ignyte Acquisition Corp, you can compare the effects of market volatilities on Ascletis Pharma and Ignyte Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascletis Pharma with a short position of Ignyte Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascletis Pharma and Ignyte Acquisition.

Diversification Opportunities for Ascletis Pharma and Ignyte Acquisition

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ascletis and Ignyte is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Ascletis Pharma and Ignyte Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ignyte Acquisition Corp and Ascletis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascletis Pharma are associated (or correlated) with Ignyte Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ignyte Acquisition Corp has no effect on the direction of Ascletis Pharma i.e., Ascletis Pharma and Ignyte Acquisition go up and down completely randomly.

Pair Corralation between Ascletis Pharma and Ignyte Acquisition

If you would invest  16.00  in Ascletis Pharma on August 26, 2024 and sell it today you would earn a total of  2.00  from holding Ascletis Pharma or generate 12.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Ascletis Pharma  vs.  Ignyte Acquisition Corp

 Performance 
       Timeline  
Ascletis Pharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ascletis Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Ascletis Pharma reported solid returns over the last few months and may actually be approaching a breakup point.
Ignyte Acquisition Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ignyte Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Ignyte Acquisition is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Ascletis Pharma and Ignyte Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ascletis Pharma and Ignyte Acquisition

The main advantage of trading using opposite Ascletis Pharma and Ignyte Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascletis Pharma position performs unexpectedly, Ignyte Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ignyte Acquisition will offset losses from the drop in Ignyte Acquisition's long position.
The idea behind Ascletis Pharma and Ignyte Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Managers
Screen money managers from public funds and ETFs managed around the world